Literature DB >> 25733073

The utility of the DDAVP challenge test in children with low von Willebrand factor.

Natasha M Archer1, Mihail Samnaliev2, Rachael Grace3, Carlo Brugnara4.   

Abstract

Entities:  

Keywords:  blood coagulation; von Willebrand disease; von Willebrand factor

Mesh：

Substances：

Year:  2015        PMID： 25733073      PMCID： PMC4558249          DOI： 10.1111/bjh.13331

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  10 in total

1.  Evaluation of high concentration intranasal and intravenous desmopressin in pediatric patients with mild hemophilia A or mild-to-moderate type 1 von Willebrand disease.

Authors:  Joan Cox Gill; Marilyn Ottum; Bruce Schwartz
Journal:  J Pediatr       Date:  2002-05       Impact factor: 4.406

2.  Inconsistency of association between type 1 von Willebrand disease phenotype and genotype in families identified in an epidemiological investigation.

Authors:  G Castaman; J C Eikenboom; R M Bertina; F Rodeghiero
Journal:  Thromb Haemost       Date:  1999-09       Impact factor: 5.249

3.  Biological and clinical response to desmopressin (DDAVP) in a retrospective cohort study of children with low von Willebrand factor levels and bleeding history.

Authors:  Analía Sánchez-Luceros; Susana S Meschengieser; Adriana I Woods; Roberto Chuit; Karina Turdó; Alicia Blanco; María A Lazzari
Journal:  Thromb Haemost       Date:  2010-09-30       Impact factor: 5.249

4.  Management of von Willebrand disease: a survey on current clinical practice from the haemophilia centres of North America.

Authors:  A J Cohen; C M Kessler; B M Ewenstein
Journal:  Haemophilia       Date:  2001-05       Impact factor: 4.287

5.  High-dose DDAVP intranasal spray (Stimate) for the prevention and treatment of bleeding in patients with mild haemophilia A, mild or moderate type 1 von Willebrand disease and symptomatic carriers of haemophilia A.

Authors:  C Leissinger; D Becton; C Cornell; J Cox Gill
Journal:  Haemophilia       Date:  2001-05       Impact factor: 4.287

6.  Post-tonsillectomy bleeding in children with von Willebrand disease: a single-institution experience.

Authors:  Kenneth D Rodriguez; Gordon H Sun; Francis Pike; Ellen M Mandel; Margaretha L Casselbrant; David H Chi
Journal:  Otolaryngol Head Neck Surg       Date:  2010-05       Impact factor: 3.497

7.  Response to desmopressin is influenced by the genotype and phenotype in type 1 von Willebrand disease (VWD): results from the European Study MCMDM-1VWD.

Authors:  Giancarlo Castaman; Stefan Lethagen; Augusto B Federici; Alberto Tosetto; Anne Goodeve; Ulrich Budde; Javier Batlle; Dominique Meyer; Claudine Mazurier; Edith Fressinaud; Jenny Goudemand; Jeroen Eikenboom; Reinhard Schneppenheim; Jorgen Ingerslev; Zdena Vorlova; David Habart; Lars Holmberg; John Pasi; Frank Hill; Ian Peake; Francesco Rodeghiero
Journal:  Blood       Date:  2008-01-29       Impact factor: 22.113

8.  Intranasal desmopressin (Octim): a safe and efficacious treatment option for children with bleeding disorders.

Authors:  K Khair; K Baker; M Mathias; C Burgess; R Liesner
Journal:  Haemophilia       Date:  2007-09       Impact factor: 4.287

9.  Desmopressin (DDAVP) responsiveness in children with von Willebrand disease.

Authors:  Shoshana Revel-Vilk; Markus Schmugge; Manuel D Carcao; Phillip Blanchette; Margaret L Rand; Victor S Blanchette
Journal:  J Pediatr Hematol Oncol       Date:  2003-11       Impact factor: 1.289

Review 10.  The diagnosis and management of von Willebrand disease: a United Kingdom Haemophilia Centre Doctors Organization guideline approved by the British Committee for Standards in Haematology.

Authors:  Mike A Laffan; Will Lester; James S O'Donnell; Andrew Will; Robert Campbell Tait; Anne Goodeve; Carolyn M Millar; David M Keeling
Journal:  Br J Haematol       Date:  2014-08-12       Impact factor: 6.998
  10 in total
  1 in total

1.  The spectrum and severity of bleeding in adolescents with low von Willebrand factor-associated heavy menstrual bleeding.

Authors:  Lakshmi Srivaths; Charles G Minard; Sarah H O'Brien; Allison P Wheeler; Eric Mullins; Mukta Sharma; Robert Sidonio; Shilpa Jain; Ayesha Zia; Margaret V Ragni; Roshni Kulkarni; Jennifer E Dietrich; Peter A Kouides
Journal:  Blood Adv       Date:  2020-07-14
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.